PMDA drug package insert
キプレスチュアブル錠5mg
PMDA Prescription drug · 杏林製薬株式会社 · package insert Jun 24, 2025
Key facts
| Brand names | キプレスチュアブル錠5mg |
|---|---|
| Nonproprietary names | モンテルカストナトリウム |
| Companies | 製造販売元／杏林製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ロイコトリエン受容体拮抗剤; 気管支喘息治療剤 |
| Therapeutic category codes | 87449 |
| YJ codes | 4490026F1044 |
| Approval numbers | 22000AMX00449000 |
| Package insert edition | 第2版 |
| Package insert date | Jun 24, 2025 |
| PMDA document key | 231099_4490026F1044_2 |
| PMDA company code | 231099 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: